Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T18:32:16.479Z.
Calculation as of: 2026-10-06T18:32:16.479Z.
Quote observation: 2026-10-06T18:28:18.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c001abb9fb130ee2b6508d8c6936c8922234201b227c8e733dd2d15e066cad3f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
MetaVia Inc.
Market Cap
$9.62M
Price/OCF Ratio
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO |
|---|---|---|
| MetaVia Inc. (MTVA) | $9.62M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.75M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.28M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $10.02M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.09M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.06M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.16M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.26M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.38M | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
